An open up-label study was carried out in 2016 in the united kingdom to analyze the feasibility, safety and efficacy of psilocybin in treating people with unipolar treatment-resistant depression with promising outcomes; Even though the review was tiny and associated only twelve people, 7 of Those people people met formal standards for remission jus… Read More